Dr Christopher Morse and his team from Manchester Metropolitan University will work with people affected by FSHD and LGMD to understand the factors that affect their quality of life, with the ultimate goal of developing ways to improve it.
Dr Jarod Wong will lead a study involving people living with muscle wasting conditions and healthcare workers to improve the accessibility and performance of bone density scanning to make monitoring weak bones more straightforward.
Rianna has been a keen gamer since she was younger and decided to fundraise for MDUK for the cause close to her heart.
Professor Zhou and team is developing a new way for treatments for collagen VI-related muscular dystrophy to reach muscle cells, helping to treat the condition and potentially reduce side effects.
Professor Tedesco and team are using mini muscles that mirror the changes seen in LMNA-related congenital muscular dystrophy to test potential new treatments.
In January 2019, we partnered with the University of Oxford to form the MDUK Oxford Neuromuscular Centre to drive forward the development of new therapies and treatments and increase the capacity of clinical trials for muscle wasting and weakening conditions in the UK. Since then, we‘ve invested over £1.2 million into the Centre.
Dr James Sleigh and colleagues from University College London will use a mouse model of SORD neuropathy to test potential gene therapies for this condition.